Adrenoceptor agonists and antagonists Flashcards
Amino acid from which catecholamines are derived
Tyrosine
Metabolic precursor of noradrenaline and adrenaline
Dopamine
Enzymes that inactive norepinephrine and epinephrine
Monoamine oxidase (MAO)
Catecholamine-O methyltransferase (COMT)
Only enzyme that metabolizes norepinephrine intraneuronally
MAO
Neuronal reuptake inhibitors that potentiate effects of norepinephrine and epinephrine
Cocaine
TCAs
Vesicular reuptake inhibitor affecting catecholamine metabolism. Used to be used for HTN.
Reserpine
Agents that inhibit MAO-A, rarely used for depression.
Clorgyline
Moclobemide
Agent that inhibits MAO-B, used in Parkinson’s disease.
Selegiline
General result of activation of alpha-1 adrenergic receptors
Gq –> Activate phospholipase C –> IP3 and DAG –> increase Ca
Causes contraction and secretion
General result of activation of alpha-2 adrenergic receptors
Gi –> inhibit adenylyl cyclase –> decrease cAMP –> decrease NT release and cause muscle contraction
General affect of activation of beta-1 adrenergic receptors
Gs –> stimulate adenylate cyclase –> increase cAMP
Increase HR, force, and renin release
General affect of activation of beta-2 adrenergic receptors
Gs –> stimulate adenylate cyclase –> increase cAMP
Relax smooth muscle
Increase glycogenolysis, HR, and force
Locations of alpha-1 adrenergic receptors
Effector tissues
Smooth muscle
Glands
Locations of alpha-2 adrenergic receptors
Nerve endings
Some smooth muscle
Locations of beta-1 adrenergic receptors
Cardiac muscle
Juxtaglomerular apparatus
Locations of beta-2 adrenergic receptors
Smooth muscle
Liver
Heart
Locations of beta-3 adrenergic receptors
Adipose cells
General affect of activation of beta-3 adrenergic receptors
Gs –> stimulate adenylate cyclase –> increase cAMP
Increase lipolysis
General affect of activation of D3 adrenergic receptors
Gs –> stimulate adenylyl cyclase –> increase cAMP
Relax renal vascular smooth muscle
Location of D3 adrenergic receptors
Smooth muscle
Only adrenergic receptor present on the presynaptic region
Alpha-2 –> inhibitory
Adrenergic receptor that, when activated, inhibits the release of norepinephrine
Alpha-2
Adrenergic receptor in pancreas that decreases insulin secretion
Alpha-2
Adrenergic receptor in pancreas that increases insulin secretion
Beta-2
Direct acting sympathomimetic drug that is a selective alpha-1 agonist
Phenylephrine
Uses of phenylephrine
Nasal decongestant
Mydriatic
Hypotension (rare)
Side effect of phenylephrine
Reflex bradycardia 2/2 increased BP and TPR
Direct acting sympathomimetic drugs that are selective alpha-2 agonists
Clonidine
Apraclonidine
Brimonidine
Reason for selective, direct-acting alpha-2 agonist use in glaucoma
Reduce aqueous humor secretion by alpha-2 action in ciliary muscles
Uses of clonidine
Moderate HTN
Migraine prophylaxis
Management of withdrawal symptoms
Menopausal hot flashes
Control diarrhea in autonomic neuropathy 2/2 DM
Adverse effects of clonidine
Dry mouth
Sedation
Nasal stuffiness
Constipation
Impotence
Centrally acting alpha-2 adrenoceptor agonist use for management of spasticity in MS
Tizanidine
Direct acting sympathomimetic drug that is a selective beta-1 agonist
Dobutamine
Effect and use of dobutamine
More selective ionotropic and chronotropic effects –> used in HF to increase CO and SV without increasing HR
Direct acting sympathomimetic drugs that are selective beta-2 agonists
Terbutaline
Albuterol
Salmeterol
Uses of selective beta-2 agonists
Immediate relief of asthma
Arrest uncomplicated premature labor (24-34 wks)
Adverse effects of beta-2 agonists
Tremors in hands
Palpitations
Hypokalemia
Direct acting sympathomimetic drug that is a selective beta-3 agonist
Mirabegron
Use of mirabegron
Overactive bladder –> urgency and frequency
Direct acting sympathomimetic drug that is a non-selective alpha-1 and alpha-2 agonist
Oxymetazoline
Direct acting sympathomimetic drug that is a non-selective beta agonist (1, 2, and 3)
Isoproterenol
Effects of isoproterenol
Significant increase: HR, CO
Significant decrease: DBP, bronchial muscle
Increase: SBP, blood flow, blood sugar
Decrease: mean BP, intestinal muscle
Effects of adrenaline/epinephrine
Significant increase: CO, SBP, blood flow to skeletal muscle and liver, blood sugar
Significant decrease: Bronchial muscle, intestinal muscle
Increase: HR, mean BP, coronary blood flow
Decrease: Blood flow to skin, mucus membranes, kidney
Effects of norepinephrine
Significant increase: SBP, DBP, mean BP
Increase: Coronary blood flow
Decrease: HR, blood flow (skin, mucus membranes, kidney), intestinal muscle
Direct acting sympathomimetic drug that is a non-selective alpha-1, alpha-2, beta-1, and beta-2 agonist. May also have weak beta-3 action.
Epinephrine
Overall cardiac effect of epinephrine
Increase SBP
Overall vascular effect of epinephrine
Decrease DBP –> decrease TPR